[
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "CXCR4",
        "binding_metric": "Kd",
        "value": "1×10−7",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "Kd",
        "value": "5×10−8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "Kd",
        "value": "2×10−8",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "Kd",
        "value": "5×10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "Kd",
        "value": "4×10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "Kd",
        "value": "3×10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "Kd",
        "value": "2×10−9",
        "unit": "M",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "30",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "15",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "10",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "5",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "3",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "28.60",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "12.51",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "2.256",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "3",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "2",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "1",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "0.9",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human CXCR4",
        "binding_metric": "EC50",
        "value": "0.8",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nPreferably, an antibody of this disclosure binds to CXCR4 with high affinity, for example with a K<sub>D </sub>of 1×10<sup>−7 </sup>M or less.\nPreferably, an antibody of this disclosure binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−8 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 5×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 4×10<sup>−9 </sup>M or less, binds to human CXCR4 with a K<sub>D </sub>of 3×10<sup>−9 </sup>M or less, or binds to human CXCR4 with a K<sub>D </sub>of 2×10<sup>−9 </sup>M or less.\nPreferably, an antibody of the inhibits binding of SDF-1 to human CXCR4 with an EC<sub>50 </sub>for inhibition of 50 nM or less, more preferably 30 nM or less, or 15 nM or less, or 10 nM or less, or 5 nM or less, or 3 nM or less (e.g., an EC<sub>50 </sub>for inhibition of 28.60 nM or less, or 12.51 nM or less, or 2.256 nM or less)\nPreferably, an antibody of this disclosure inhibits SDF-1-induced calcium flux in cells expressing human CXCR4 with an EC<sub>50 </sub>for inhibition of 3 nM or less, more preferably 2 nM or less, or 1 nM or less, or 0.9 nM or less, or 0.8 nM or less,"
    },
    {
        "molecule_name": "R16",
        "protein_target_name": "CXCR4",
        "binding_metric": "EC50",
        "value": "2.3",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nThe EC<sub>50 </sub>values for binding are shown in Table 2.\nCell TypeEC<sub>50 </sub>(nM)R1610-huCXCR42.3Ramos4.2CEM10.3Nomo-140HL-605.3MOLP-86.5JJN-3R2.0\nThe EC<sub>50</sub>'s for CXCL12 blockade by F7, F9 and D1 were 2.3 nM, 12.5 nM and 28.6 nM, respectively."
    },
    {
        "molecule_name": "J.JN-3",
        "protein_target_name": "R2",
        "binding_metric": "EC50",
        "value": "2.0",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nThe EC<sub>50 </sub>values for binding are shown in Table 2.\nCell TypeEC<sub>50 </sub>(nM)R1610-huCXCR42.3Ramos4.2CEM10.3Nomo-140HL-605.3MOLP-86.5JJN-3R2.0\nThe EC<sub>50</sub>'s for CXCL12 blockade by F7, F9 and D1 were 2.3 nM, 12.5 nM and 28.6 nM, respectively."
    },
    {
        "molecule_name": "Ulocuplumab",
        "protein_target_name": "CXCL12",
        "binding_metric": "EC50",
        "value": "12.44",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences:\n\nThe EC<sub>50</sub>'s for inhibition of CXCL12-induced CEM cell migration by F7 and F9 were 12.44 nM and 18.99 nM, respectively.\nBMS-936564 was shown to block CXCL12-induced migration with an approximate EC<sub>50 </sub>value of 1 nM in Ramos cells and 4 nM in CEM cells (FIGS. 10A and 10B).\nAnti-CXCL12 inhibited CXCL12-induced migration with an approximate EC50 value of 0.9 nM (Ramos) and 0.13 nM (CEM) cells (FIGS. 10A and 10B).\nThe optimal concentration of CXCL12 for inducing Ramos migration was established to be 10 ng/mL (1.25 nM) while CEM cells were more sensitive to CXCL12 and exhibited maximal migration at 0.05 nM CXCL12."
    },
    {
        "molecule_name": "F9",
        "protein_target_name": "CXCL12",
        "binding_metric": "EC50",
        "value": "18.99",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences:\n\nThe EC<sub>50</sub>'s for inhibition of CXCL12-induced CEM cell migration by F7 and F9 were 12.44 nM and 18.99 nM, respectively.\nBMS-936564 was shown to block CXCL12-induced migration with an approximate EC<sub>50 </sub>value of 1 nM in Ramos cells and 4 nM in CEM cells (FIGS. 10A and 10B).\nAnti-CXCL12 inhibited CXCL12-induced migration with an approximate EC50 value of 0.9 nM (Ramos) and 0.13 nM (CEM) cells (FIGS. 10A and 10B).\nThe optimal concentration of CXCL12 for inducing Ramos migration was established to be 10 ng/mL (1.25 nM) while CEM cells were more sensitive to CXCL12 and exhibited maximal migration at 0.05 nM CXCL12."
    },
    {
        "molecule_name": "BMS-936564",
        "protein_target_name": "CXCL12",
        "binding_metric": "EC50",
        "value": "1",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences:\n\nThe EC<sub>50</sub>'s for inhibition of CXCL12-induced CEM cell migration by F7 and F9 were 12.44 nM and 18.99 nM, respectively.\nBMS-936564 was shown to block CXCL12-induced migration with an approximate EC<sub>50 </sub>value of 1 nM in Ramos cells and 4 nM in CEM cells (FIGS. 10A and 10B).\nAnti-CXCL12 inhibited CXCL12-induced migration with an approximate EC50 value of 0.9 nM (Ramos) and 0.13 nM (CEM) cells (FIGS. 10A and 10B).\nThe optimal concentration of CXCL12 for inducing Ramos migration was established to be 10 ng/mL (1.25 nM) while CEM cells were more sensitive to CXCL12 and exhibited maximal migration at 0.05 nM CXCL12."
    },
    {
        "molecule_name": "BMS-936564",
        "protein_target_name": "CXCL12",
        "binding_metric": "EC50",
        "value": "4",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences:\n\nThe EC<sub>50</sub>'s for inhibition of CXCL12-induced CEM cell migration by F7 and F9 were 12.44 nM and 18.99 nM, respectively.\nBMS-936564 was shown to block CXCL12-induced migration with an approximate EC<sub>50 </sub>value of 1 nM in Ramos cells and 4 nM in CEM cells (FIGS. 10A and 10B).\nAnti-CXCL12 inhibited CXCL12-induced migration with an approximate EC50 value of 0.9 nM (Ramos) and 0.13 nM (CEM) cells (FIGS. 10A and 10B).\nThe optimal concentration of CXCL12 for inducing Ramos migration was established to be 10 ng/mL (1.25 nM) while CEM cells were more sensitive to CXCL12 and exhibited maximal migration at 0.05 nM CXCL12."
    },
    {
        "molecule_name": "CXCL12",
        "protein_target_name": "CXCL12",
        "binding_metric": "EC50",
        "value": "0.9",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences:\n\nThe EC<sub>50</sub>'s for inhibition of CXCL12-induced CEM cell migration by F7 and F9 were 12.44 nM and 18.99 nM, respectively.\nBMS-936564 was shown to block CXCL12-induced migration with an approximate EC<sub>50 </sub>value of 1 nM in Ramos cells and 4 nM in CEM cells (FIGS. 10A and 10B).\nAnti-CXCL12 inhibited CXCL12-induced migration with an approximate EC50 value of 0.9 nM (Ramos) and 0.13 nM (CEM) cells (FIGS. 10A and 10B).\nThe optimal concentration of CXCL12 for inducing Ramos migration was established to be 10 ng/mL (1.25 nM) while CEM cells were more sensitive to CXCL12 and exhibited maximal migration at 0.05 nM CXCL12."
    },
    {
        "molecule_name": "CXCL12",
        "protein_target_name": "CXCL12",
        "binding_metric": "EC50",
        "value": "0.13",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences:\n\nThe EC<sub>50</sub>'s for inhibition of CXCL12-induced CEM cell migration by F7 and F9 were 12.44 nM and 18.99 nM, respectively.\nBMS-936564 was shown to block CXCL12-induced migration with an approximate EC<sub>50 </sub>value of 1 nM in Ramos cells and 4 nM in CEM cells (FIGS. 10A and 10B).\nAnti-CXCL12 inhibited CXCL12-induced migration with an approximate EC50 value of 0.9 nM (Ramos) and 0.13 nM (CEM) cells (FIGS. 10A and 10B).\nThe optimal concentration of CXCL12 for inducing Ramos migration was established to be 10 ng/mL (1.25 nM) while CEM cells were more sensitive to CXCL12 and exhibited maximal migration at 0.05 nM CXCL12."
    }
]